Recent Finacing
Recent Raise
GlyGenix Therapeutics develops gene therapies for genetic metabolic disorders, advancing AAV-G6Pase as a treatment candidate for glycogen storage disease type 1a from Woodbridge, Connecticut.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor